| 今开：26.92 | 昨收：26.85 |
| 最高：27.61 | 最低：25.59 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.497667449E9 |
产业链观察03-11 21:20
#药闻简讯# 2024 年 3 月 11 日/Protagonist Therapeutics, Inc$Protagonist(PTGX)$ 今天在美国皮肤病学会（AAD）2024 年年会上宣布了一项重大突破，即对 JNJ-2113 进行 2b 期 FRONTIER 2 长期扩展研究的积极结果，JNJ-2113 是首个也是唯一一个用于阻断 IL-23 受体的研究性靶向口服肽，适用于中重...查看全文
chuminhua02-04 12:13
2/1，武田（Takeda）$武田制药(TAK)$ 和 Protagonist Therapeutics $Protagonist(PTGX)$ 已就后者的铁调素模拟肽候选药物 rusfertide 的开发和商业化签订了全球许可和合作协议，该药物目前正处于真性红细胞增多症 (PV) 的 III 期研究中。
在周三宣布的 50:50 利润分成协议中，武田将向 Protago...查看全文
Protagonist(PTGX)02-15 06:05
$Protagonist(PTGX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-023959 Act: 34 Size: 138 KB 网页链接查看全文
Protagonist(PTGX)02-14 22:35
$Protagonist(PTGX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000921895-24-000437 Act: 34 Size: 280 KB 网页链接查看全文
Protagonist(PTGX)02-14 20:25
$Protagonist(PTGX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001553 Act: 34 Size: 65 KB 网页链接查看全文
Protagonist(PTGX)02-01 05:15
$Protagonist(PTGX)$ 8-K Current report, item 1.01 Accession Number: 0001104659-24-008787 Act: 34 Size: 214 KB 网页链接查看全文
Protagonist(PTGX)02-28 05:55
$Protagonist(PTGX)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-24-028247 Act: 33 Size: 79 KB 网页链接查看全文
Protagonist(PTGX)02-29 09:05
$Protagonist(PTGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-028888 Size: 5 KB 网页链接查看全文
Protagonist(PTGX)04-13 04:35
$Protagonist(PTGX)$ PRE 14A Other preliminary proxy statements Accession Number: 0001104659-24-046797 Act: 34 Size: 2 MB 网页链接查看全文
Protagonist(PTGX)03-01 06:55
$Protagonist(PTGX)$ 144 Report of proposed sale of securities Accession Number: 0001972362-24-000257 Act: 33 Size: 4 KB 网页链接查看全文
Protagonist是一个市值10亿美元左右，市净率3倍多的与强生有重要合作的公司，我之前不知道这家公司，是看到疑夕的微博才注意到这个公司。 这个公司目前17美元/股，前底4美元多，足足涨了4倍多，即便从最近8美元左右，也是3个季度翻倍... 网页链接
$Protagonist(PTGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-049567 Size: 5 KB 网页链接
$Protagonist(PTGX)$ PRE 14A Other preliminary proxy statements Accession Number: 0001104659-24-046797 Act: 34 Size: 2 MB 网页链接
$Protagonist(PTGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-042744 Size: 5 KB 网页链接
$Protagonist(PTGX)$ 144 Report of proposed sale of securities Accession Number: 0001968582-24-000271 Act: 33 Size: 5 KB 网页链接
$Protagonist(PTGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-033132 Size: 6 KB 网页链接
$Protagonist(PTGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-030159 Size: 5 KB 网页链接
$Protagonist(PTGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-030157 Size: 9 KB 网页链接
$Protagonist(PTGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-030156 Size: 14 KB 网页链接
$Protagonist(PTGX)$ 144 Report of proposed sale of securities Accession Number: 0001972362-24-000296 Act: 33 Size: 6 KB 网页链接
$Protagonist(PTGX)$ 144 Report of proposed sale of securities Accession Number: 0001968582-24-000154 Act: 33 Size: 7 KB 网页链接